CAPN5

calpain 5, the group of Calpains|C2 domain containing

Basic information

Region (hg38): 11:77066961-77126155

Previous symbols: [ "VRNI" ]

Links

ENSG00000149260NCBI:726OMIM:602537HGNC:1482Uniprot:O15484AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant neovascular inflammatory vitreoretinopathy (Moderate), mode of inheritance: AD
  • autosomal dominant neovascular inflammatory vitreoretinopathy (Supportive), mode of inheritance: AD
  • CAPN5-related vitreoretinopathy (Definitive), mode of inheritance: AD
  • CAPN5-related vitreoretinopathy (Strong), mode of inheritance: AD
  • CAPN5-related vitreoretinopathy (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Vitreoretinopathy, neovascular inflammatoryADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic23055945

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CAPN5 gene.

  • not_provided (620 variants)
  • Inborn_genetic_diseases (116 variants)
  • not_specified (40 variants)
  • CAPN5-related_disorder (24 variants)
  • Retinal_dystrophy (15 variants)
  • Proliferative_vitreoretinopathy (7 variants)
  • Autosomal_dominant_neovascular_inflammatory_vitreoretinopathy (5 variants)
  • High_myopia (1 variants)
  • Severe_early-childhood-onset_retinal_dystrophy (1 variants)
  • Occult_macular_dystrophy (1 variants)
  • Late-onset_cone-rod_dystrophy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAPN5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004055.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
7
clinvar
137
clinvar
15
clinvar
159
missense
4
clinvar
314
clinvar
27
clinvar
6
clinvar
351
nonsense
14
clinvar
14
start loss
0
frameshift
16
clinvar
1
clinvar
17
splice donor/acceptor (+/-2bp)
5
clinvar
5
Total 4 0 356 165 21
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CAPN5protein_codingprotein_codingENST00000278559 1259223
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.52e-80.99512562401241257480.000493
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5343944250.9270.00002954179
Missense in Polyphen158188.810.836841866
Synonymous0.07351771780.9930.00001291250
Loss of Function2.561834.10.5270.00000190345

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001180.00117
Ashkenazi Jewish0.001290.00129
East Asian0.0007630.000761
Finnish0.00004640.0000462
European (Non-Finnish)0.0005410.000536
Middle Eastern0.0007630.000761
South Asian0.0002630.000261
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Calcium-regulated non-lysosomal thiol-protease. {ECO:0000250}.;
Disease
DISEASE: Vitreoretinopathy, neovascular inflammatory (VRNI) [MIM:193235]: An autoimmune condition of the eye that sequentially mimics uveitis, retinitis pigmentosa, and proliferative diabetic retinopathy as it progresses to complete blindness. Patients present during the second or third decade of life with posterior uveitis and reduction of the electroretinogram b-wave. They become more symptomatic when cataracts, cystoid macular edema, and disk edema diminish visual acuity during the second stage. Severe vision loss begins during the third stage when proliferative retinal neovascularization and epiretinal membranes appear. There is an ongoing pigmentary retinal degeneration and peripheral visual field loss during all stages. In the fourth stage, proliferative vitreoretinopathy causes tractional retinal detachments at the macula and vitreous base. The fifth or end- stage disease is marked by phthisis. {ECO:0000269|PubMed:23055945}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Integrin-mediated Cell Adhesion;Extracellular matrix organization;Degradation of the extracellular matrix (Consensus)

Recessive Scores

pRec
0.116

Intolerance Scores

loftool
0.214
rvis_EVS
-0.9
rvis_percentile_EVS
10.14

Haploinsufficiency Scores

pHI
0.238
hipred
N
hipred_score
0.289
ghis
0.467

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.392

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Capn5
Phenotype
growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
proteolysis;signal transduction
Cellular component
cytoplasm;focal adhesion;cell surface;extracellular exosome
Molecular function
calcium-dependent cysteine-type endopeptidase activity